TRILEXA BEXICAP 200/62.5/25

TRILEXA BEXICAP 200/62.5/25

Availability :

Out Of Stock

Product Code : 103110142900601

Short Description

A triple combination capsule for long-term control of severe asthma and COPD symptoms in adults.

Name	Brand	Generic Name	Strength	PPF	Price
TRILEXA BEXICAP 200/62.5/25	Beximco Pharmaceuticals Ltd.	FLUTICASONE FUROATE UMECLIDINIUMTRILEXA BEXICAP	200/62.5/25	Capsule	90

৳ 90

Select Color

Select Size

Qty :

Description

রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন।

Indications
TRILEXA BEXICAP 200/62.5/25 MG is indicated for maintenance treatment of moderate to severe asthma and chronic obstructive pulmonary disease (COPD) in adult patients who require a combination of an ICS, LABA, and LAMA.

Pharmacology
This medication combines:

Inhaled corticosteroid (ICS) – reduces airway inflammation.
Long-acting beta2-agonist (LABA) – relaxes bronchial muscles.
Long-acting muscarinic antagonist (LAMA) – improves airflow and reduces mucus secretion.
The combination works synergistically to provide better control of chronic respiratory conditions.

Dosage & Administration
One capsule is to be inhaled once daily using the prescribed dry powder inhalation device. Do not swallow the capsule. Proper inhalation technique is essential for effectiveness.

Interaction
May interact with systemic corticosteroids, beta-blockers, ketoconazole, and other anticholinergic drugs. Inform your physician about all medications you are taking.

Contraindications
Contraindicated in patients with hypersensitivity to any component of the formulation. Not to be used for emergency treatment of acute bronchospasm.

Side Effects
Common side effects: cough, dry mouth, sore throat, headache, and hoarseness.
Serious (but rare): increased heart rate, tremor, glaucoma exacerbation, or urinary retention.

Pregnancy & Lactation
Use only if clearly needed and prescribed by a healthcare provider. The risk-benefit ratio should be assessed for pregnant or lactating women.

Precautions & Warnings
Use with caution in patients with cardiovascular disease, seizure disorders, thyroid abnormalities, glaucoma, or diabetes. Avoid sudden discontinuation.

Therapeutic Class
Triple combination therapy (ICS + LABA + LAMA) for respiratory diseases.

Storage Conditions
Store below 30°C in a dry place, away from sunlight and moisture. Keep out of reach of children. Use capsules only with the device provided.

Related products

Sale